city New Delhi India covid-19 patient Health city New Delhi India

Treatment of covid-19 with fluvoxamine reduces risk of prolonged hospitalization: study

Reading now: 494
www.livemint.com

NEW DELHI : Using fluvoxamine to treat high-risk outpatients with early-diagnosed covid-19 reduced the need for prolonged observation in an emergency setting or hospitalisation when compared to a control group who received a placebo during a randomised clinical trial, the results of which were published in The Lancet Global Health on Wednesday.

Fluvoxamine is currently used to treat mental health conditions such as depression and obsessive-compulsive disorders. It was chosen for study as a potential treatment for covid-19 due to its anti-inflammatory properties. “Fluvoxamine may reduce the production of inflammatory molecules called cytokines, that can be triggered by SARS-CoV-2 infection," Dr Angela Reiersen, Associate Professor of

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA